Glycema Tablet 10 mg
Glycema Tablet 10 mg Uses, Dosage, Side Effects, Food Interaction and all others data.
Trade Name | Glycema Tablet 10 mg |
Generic | Dapagliflozin Propanediol |
Weight | 10 mg |
Type | Tablet |
Therapeutic Class | Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors |
Manufacturer | ACI Limited |
Available Country | Bangladesh |
Last Updated: | October 19, 2023 at 6:27 am |
Uses
Dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitusDosage
Glycema Tablet 10 mg dosage
5 mg orally once a day.May increase to 10 mg orally once a day in patients tolerating therapy with 5 mg and requiring additional glycemic controlSide Effects
Renal impairment, Female genital mycotic infections, Urinary tract infection, Increased urination, Male genital mycotic infections, Dyslipidemia, Constipation, Discomfort with urination, Extremity pain, Volume depletion, HypersensitivityPrecaution
CV disease, history of hypotension, UTI, Children, Elderly. Unknown whether distributed in human breast milk; breastfeeding women should discontinue dapagliflozin or nursing taking into account the importance of the drug to the motherInteraction
Hypoglycemia may occur with concomitant use with insulin & insulin secretagogues eg sulfonylureas. Decrease in Cmax & AUC with rifampin. Increase in Cmax & AUC with mefenamic acid. Increased thiazide & loop diuretic effects; may increase risk of dehydration & hypotension. Pioglitazone.Pregnancy & Breastfeeding use
Pregnancy Category-C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risksContraindication
Hypersensitivity to dapagliflozin propanediol or to any of the excipients. Moderate to severe renal impairment; end-stage renal disease; active bladder cancer. Pregnancy (2nd & 3rd trimester) & lactation.Special Warning
Renal Impairment: No dosage adjustment is indicated based on renal function. The efficacy is dependent on renal function. lt is not recommended for use in patients with moderate to severe renal impairment (patients with CrCI <60 mL/min or eGFR <60 mL/min/1.73 m2).Innovators Monograph
You find simplified version here Glycema Tablet 10 mg